Macrophages prevent human red blood cell reconstitution in immunodeficient mice

Blood

Volumn 118, Issue 22, 2011, Pages 5938-5946

  Hu, Zheng ^a,b,c   Van Rooijen, Nico ^d   Yang, Yong Guang ^b,c  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BB1501 ^*  (United States)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIGEN; ERYTHROPOIETIN; INTERLEUKIN 3;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CD34 SELECTION; CELL FUNCTION; CELL MATURATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROID CELL; ERYTHROPOIESIS; FETUS; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMUS; TREATMENT WITHDRAWAL;

EID: 82155178696     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-11-321414     Document Type: Article

References (48)

1. Wellems TE, Hayton K, Fairhurst RM. The impact of malaria parasitism: from corpuscles to communities. J Clin Invest. 2009;119(9):2496-2505.
2. Flygare J, Karlsson S. Diamond-Blackfan anemia: erythropoiesis lost in translation. Blood. 2007;109(8):3152-3154.
3. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108(8):2509-2519.
4. Taniguchi T, D'Andrea AD. Molecular pathogenesis of Fanconi anemia: recent progress. Blood. 2006;107(11):4223-4233. (Pubitemid 43801344)
5. Kaufman DS. Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. Blood. 2009;114(17):3513-3523.
6. Lu SJ, Feng Q, Park JS, et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood. 2008;112(12):4475-4484.
7. Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol. 2007;7(2):118-130. (Pubitemid 46174859)
8. Ishikawa F, Yasukawa M, Lyons B, et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor gamma chain- (null) mice. Blood. 2005;106(5):1565-1573. (Pubitemid 41208567)
9. Manz MG, Di Santo JP. Renaissance for mouse models of human hematopoiesis and immunobiology. Nat Immunol. 2009;10(10):1039-1042.
10. Chen Q, Khoury M, Chen J. Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc Natl Acad Sci U S A. 2009;106(51): 21783-21788.
11. Lan P, Wang L, Diouf B, et al. Induction of human T-cell tolerance to porcine xenoantigens through mixed hematopoietic chimerism. Blood. 2004; 103(10):3964-3969. (Pubitemid 38596320)
12. Lan P, Tonomura N, Shimizu A, Wang S, Yang YG. Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood. 2006;108(2):487-492. (Pubitemid 44061346)
13. Tonomura N, Habiro K, Shimizu A, Sykes M, Yang YG. Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model. Blood. 2008;111(8):4293-4296.
14. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods. 1994;174(1-2):83-93.
15. Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP. Role of CD47 as a marker of self on red blood cells. Science. 2000;288(5473):2051-2054. (Pubitemid 30397687)
16. Wang H, Madariaga ML, Wang S, Van Rooijen N, Oldenborg PA, Yang YG. Lack of CD47 on non-hematopoietic cells induces split macrophage tolerance to CD47null cells. Proc Natl Acad Sci U S A. 2007;104(34):13744-13749. (Pubitemid 350003391)
17. Qiu LB, Dickson H, Hajibagheri N, Crocker PR. Extruded erythroblast nuclei are bound and phagocytosed by a novel macrophage receptor. Blood. 1995;85(6):1630-1639.
18. Loken MR, Shah VO, Dattilio KL, Civin CI. Flow cytometric analysis of human bone marrow: I. Normal erythroid development. Blood. 1987; 69(1):255-263. (Pubitemid 17007105)
19. Lok CN, Ponka P. Identification of an erythroid active element in the transferrin receptor gene. J Biol Chem. 2000;275(31):24185-24190. (Pubitemid 30627464)
20. Miharada K, Hiroyama T, Sudo K, Nagasawa T, Nakamura Y. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol. 2006; 24(10):1255-1256. (Pubitemid 44564771)
21. Giarratana MC, Kobari L, Lapillonne H, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol. 2005;23(1):69-74. (Pubitemid 41724627)
22. Ito M, Hiramatsu H, Kobayashi K, et al. NOD/ SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002;100(9):3175-3182. (Pubitemid 35217065)
23. Fraser CC, Chen BP, Webb S, van Rooijen N, Kraal G. Circulation of human hematopoietic cells in severe combined immunodeficient mice after Cl2MDP liposome-mediated macrophage depletion. Blood. 1995;86(1):183-192.
24. Hayakawa J, Hsieh MM, Anderson DE, et al. The assessment of human erythroid output in NOD/ SCID mice reconstituted with human hematopoietic stem cells. Cell Transplant. 2010;19(11): 1465-1473.
25. Jiang P, Lagenaur CF, Narayanan V. Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J Biol Chem. 1999;274(2): 559-562.
26. Vernon-Wilson EF, Kee WJ, Willis AC, Barclay AN, Simmons DL, Brown MH. CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPalpha 1. Eur J Immunol. 2000;30(8):2130-2137. (Pubitemid 30655751)
27. Blazar BR, Lindberg FP, Ingulli E, et al. CD47 (integrin- associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells. J Exp Med. 2001;194(4): 541-549. (Pubitemid 32835048)
28. Takenaka K, Prasolava TK, Wang JC, et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol. 2007;8(12):1313-1323. (Pubitemid 350138972)
29. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 1988;241(4873):1632-1639.
30. Wang H, VerHalen J, Madariaga ML, et al. Attenuation of phagocytosis of xenogeneic cells by manipulating CD47. Blood. 2007;109(2):836-842. (Pubitemid 46105989)
31. Ide K, Wang H, Tahara H, et al. Role for CD47- SIRPalpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci U S A. 2007; 104(12):5062-5066. (Pubitemid 47186176)
32. Oldenborg PA, Gresham HD, Lindberg FP. CD47- signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis. J Exp Med. 2001;193(7):855-862.
33. Oldenborg PA, Gresham HD, Chen Y, Izui S, Lindberg FP. Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice. Blood. 2002;99(10):3500-3504. (Pubitemid 34534515)
34. Burlak C, Twining LM, Rees MA. Terminal sialic acid residues on human glycophorin A are recognized by porcine Kupffer cells. Transplantation. 2005;80(3):344-352. (Pubitemid 41129963)
35. Jin R, Greenwald A, Peterson MD, Waddell TK. Human monocytes recognize porcine endothelium via the interaction of galectin 3 and alpha- GAL. J Immunol. 2006;177(2):1289-1295. (Pubitemid 44036635)
36. Tonomura N, Shimizu A, Wang S, et al. Pig islet xenograft rejection in a mouse model with an established human immune system. Xenotransplantation. 2008;15(2):129-135. (Pubitemid 351601117)
37. Clark SC, Kamen R. The human hematopoietic colony-stimulating factors. Science. 1987; 236(4806):1229-1237. (Pubitemid 17087886)
38. Leary AG, Yang YC, Clark SC, Gasson JC, Golde DW, Ogawa M. Recombinant gibbon interleukin 3 supports formation of human multilineage colonies and blast cell colonies in culture: comparison with recombinant human granulocyte-macrophage colony-stimulating factor. Blood. 1987; 70(5):1343-1348. (Pubitemid 18026136)
39. Saeland S, Caux C, Favre C, et al. Effects of recombinant human interleukin-3 on CD34-enriched normal hematopoietic progenitors and on myeloblastic leukemia cells. Blood. 1988;72(5): 1580-1588. (Pubitemid 18268638)
40. Sonoda Y, Yang YC, Wong GG, Clark SC, Ogawa M. Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony- stimulating factor are specific for early developmental stages. Proc Natl Acad Sci U S A. 1988;85(12):4360- 4364.
41. Bruno E, Briddell R, Hoffman R. Effect of recombinant and purified hematopoietic growth factors on human megakaryocyte colony formation. Exp Hematol. 1988;16(5):371-377.
42. Wodnar-Filipowicz A, Heusser CH, Moroni C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature. 1989;339(6220):150-152. (Pubitemid 19122273)
43. Oster W, Lindemann A, Mertelsmann R, Herrmann F. Production of macrophage-, granulocyte-, granulocyte-macrophage- and multi-colony- stimulating factor by peripheral blood cells. Eur J Immunol. 1989;19(3):543-547. (Pubitemid 19128564)
44. Kita H, Ohnishi T, Okubo Y, Weiler D, Abrams JS, Gleich GJ. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med. 1991;174(3):745-748.
45. Sathyanarayana P, Houde E, Marshall D, et al. CNTO 530 functions as a potent EPO mimetic via unique sustained effects on bone marrow proerythroblast pools. Blood. 2009;113(20):4955-4962.
46. Metcalf D. Control of granulocytes and macrophages: molecular, cellular, and clinical aspects. Science. 1991;254(5031):529-533. (Pubitemid 21917365)
47. Lu L, Briddell RA, Graham CD, Brandt JE, Bruno E, Hoffman R. Effect of recombinant and purified human haematopoietic growth factors on in vitro colony formation by enriched populations of human megakaryocyte progenitor cells. Br J Haematol. 1988;70(2):149-156.
48. Teramura M, Katahira J, Hoshino S, Motoji T, Oshimi K, Mizoguchi H. Clonal growth of human megakaryocyte progenitors in serum-free cultures: effect of recombinant human interleukin 3. Exp Hematol. 1988;16(10):843-848.